Volodymyr Kostiuk was appointed the Acting Executive Director in March 2018. Before that, he had held the position of the Operations Director of the company since June 2015. Before that, he was the chief of the liquid and semisolid medicinal products manufacturing shop. He has worked in the Company since 2008.
Volodymyr Kostiuk worked on establishing contacts with foreign partners and development of pharmaceutical enterprise’s international cooperation. He participated in clinical trials of preparations manufactured by Farmak in Europe, Canada and the US. Volodymyr Kostiuk headed the team in charge of the operation of SAP ERP, a business automation system, and was responsible for internal audits in the company.
Volodymyr Kostiuk is responsible for development and implementation of the company strategy in manufacturing operations, introduction of efficient business processes into production, management of production activities of the enterprise and processes of development and expansion of production.
In 2009, he graduated from Taras Shevchenko National University of Kyiv with a degree in Economic Cybernetics. He studied at Donau Universitat Krems (Austria) under the MBA program.
Now he is studying at National University of Pharmacy, Kharkiv to obtain a degree in Pharmaceutical Engineering.
Alexandra Sologub, MD, MBA, is Director of “Likravy” Ukraine, belonging to the nature network® - the group of companies, managed as a family company in its third generation and operated internationally in more than 60 countries. The nature network® offers a broad spectrum of products and services: from botanicals and their refinement into premium-quality base materials, to laboratory, consultancy and distribution services.
Alexandra has an experience of approximately 20 years in Pharma industry; she has worked in different organizations like GSK, Teva, Darnitsa.
Deepak Sharma is Director of Glenmark Ukraine, belonging to Glenmark Pharmaceuticals Ltd., an International pharma company with presence over 80 countries. Glenmark Pharma Ranks among top 80 Pharma & Biotech companies globally. (SCRIP 100 Rankings 2017). Glenmark pharma has 17 manufacturing facilities across US, India, Czech Republic, Argentina and Switzerland.
In addition to Ukraine, Deepak is also looking after Moldova, Georgia and Azerbaijan. In this role, Deepak is responsible for overall operations of the organization.
Deepak has an experience of apprx 15 years in Pharma industry, he has worked in different organizations like Cipla, Pfizer, Ranbaxy & Macleods on different positions. He is based in Ukraine from last 7 years and travelled extensively inside the region including, Ukraine , Kazak, Uzbek, Georgia, Azerbaijan and Moldova. He possesses a good knowledge of the pharma industry in the region. He has a vision to develop the pharma marketing more interesting and innovative. He is instrumental in many of the ongoing CSR projects in the region.
Deepak holds a Management degree, in addition to the life-sciences degree. Deepak has spoken on various issues on various platform related to pharma Industry. He is often invited by management colleges for talk to inspire students. In the recent past , Deepak was interviewed by Pharmaboard room and Medicinman. His interview on his career was published in Medicinman last year.
Deepak lives in Kyiv with wife and 2 children.
Alexander Tkachuk graudated from Canada New Brunswick University with international MBA. He also has a 'Marketing degree' from Economical University in Kiev and degrees from the Institute of Pharmacology at Academy of Medical Science, Kiev and National Medical University, Kiev.
Before his role as a Country Manager in the Representative Office Sentiss Pharma, Ukraine
Alexander used to be a Head of Business Support & Development department in the representative office of Sanofi in Ukraine, General Manager at COMCON Pharma (Ukraine) and Deputy Country Manager at the Representative office of Mega Products in Ukraine.
Leonid received his Master of Law degree at The Yaroslav Mudryi National Law University and reinforced his academic background by studying Economics, Finance and Credit at V.N. Karazin Kharkiv National University.
He joined Sanofi Ukraine in 2015, having brought the extensive experience he gained as an associate at Ukraine’s leading law firms.
As Head of Legal, Mr. Cherniavskyi is providing in-depth, legal, business-focused advice to the business, identifying and assessing the issues impacting legal risk while keeping a special focus on setting standards and reinforcing a culture of integrity, quality, ethical behavior and responsibility across the Sanofi business in Ukraine.
Alla has been woring as a Director of Medical and Regulatory Affairs department, PV, QA Ukraine and CIS in Acino Pharma AG, Pharma Start LLC Ukraine since 2015. From 2003 to 2015 she was a medical representaive to RA, Medical, PV, QA Director in group of countries at Nycomed (Switzerland), Takeda Pharmaceutical (Japan). Alla graduated as a MD from National Medical University (Ukraine, Kiev) in 2003. Alla has a PhD in Pediatrics.
Daria graduated from Kyiv National University of Trade and Economics, with MA degree in Finance and Credit as Financial analyst. She has a degree in Commercial Law from Kyiv National University of Trade and Economics, in Law from Vadym Getman Kyiv National Economic University.
Legal career of D. Bondarenko began in the Kyiv City Clinical Hospital No. 1 of the Main Health Department of the Kyiv City State Council (KCSC) as a lawyer of the special fund health insurance department.
At the same time, Daria Bondarenko was an assistant-consultant of the deputy head of Main Health Department of the KCSC (now KCSC Health Department).
By the decision of AMOMD founders general meeting D. Bondarenko was elected at Nov. 7, 2012 to the position of Executive Director and combined this work in Nov. 2014 with a legal practice in leading law company “Legal Alliance”.
According to Association Article the Executive Director represents AMOMD in relations with central and local authorities, other state and non-governmental Ukrainian, foreign and international organizations, enterprises, individuals and acts on behalf of the Association.
Implemented projects with D. Bondarenko participation:
• Draft Law No. 3180 “On the amendments to the item 193.1 “в” of article 193 of the Tax Code of Ukraine” dated by Sep. 25, 2015;
• Cabinet of Ministers Resolution No. 181 “On the amendments of certain CMR decrees” dated by May 27, 2014;
• Cabinet of Ministers Resolution No. 215 “On the amendments of certain CMR decrees” dated by July 01, 2014;
• Cabinet of Ministers Resolution No. 216 “On approval of medical devices, which operations for delivery in the customs territory of Ukraine and importation into the customs territory of Ukraine are to be taxable for VAT at the rate of 7 percents” dated by July 01, 2014;
• Cabinet of Ministers Resolution No. 240 “On the amendments of certain CMR decrees” dated by March 23, 2016;
• Cabinet of Ministers Resolution No. 501 “On Amendments to the CMR reglament (in respect of changes to item 2 of paragraph 40 for Chapter 3)” dated by Aug. 08, 2016;
• Cabinet of Ministers Resolution No. 43 ‘On Amendments to the CMR order of Oct. 17, 2008, No. 955 and to the CMR order of Jul. 02, 2014, No. 240” dated by January 25, 2017 – regarding the cancellation of change declaring of the wholesale-sale price for medical devices;
• MHU order No. 660 “On the recognition of the MHU order of Dec. 29, 2011, No. 1000, as invalid one” dated by Oct. 09, 2015;
• MHU order No.361 “On amending the MHU order of July 16, 2012 No. 533” dated by April 13, 2016.
Pharmaceutic regulation, legal regulation of medical devices legalization, price control and VAT taxation of medical devices, technical regulation of medical devices, regulatory activity
• working group of Ministry of Economic Development and Trade of Ukraine on improving the assessment of compliance of legislatively regulated measuring instruments used to ensure the protection of citizens life and health;
• working group on the legislation improvement in the sphere of medicinal products circulation of the Ministry of Health of Ukraine;
• community council attached to AMCU;
• Ukrainian Bar Association (UBA)
Pavlo graduated from O.O. Bogomolets National Medical University with a degree in General Medicine as a General Practitioner − Family Doctor. Pavlo also got a degree in Pharmacy as a Pharmacist.
Pavlo Kharchyk started his career in the pharmaceutical busines while studying at the National Medical University as a representative, and later as a sales manager of Bolear Med Co. After this company and graduation, he worked as a medical representative of the Beaufour Ipsen Pharma company in Ukraine. In parallel, he worked as an intern at KCCH No. 2. Then he acted as the director of the company “Kalina Pharma” and the marketing manager, and later the director of the “Kalina company for business development.” Today his main workplace is the “Kalina Medical Production Company”, where he works as a director.
During academic studies he received the awards from the Kyiv mayor, an academic scholarship of the President of Ukraine. Representation office of “Beaufour Ipsen Pharma” awarded him by a certificate of the best medical representative of 2008 in the EurAsia 5 region.
He was rewarded “For the Service in Professional Activity” for his significant contribution to the development of Ukrainian economy.
He was awarded by the honorary title “BEST MANAGER OF THE YEAR” for a significant contribution to the development of the Ukrainian economy and strong leadership in 2013.
He holds the position of President of Association “Operators of the medical devices market” since 2012 for which he has been re-elected annually.
Implemented projects with P. Kharchyk participation:
Draft Law No. 3180 “On the amendments to the item 193.1 “в” of article 193 of the Tax Code of Ukraine” dated by Sep. 25, 2015;
Cabinet of Ministers Resolution No. 181 “On the amendments of certain CMR decrees” dated by May 27, 2014;
Cabinet of Ministers Resolution No. 215 “On the amendments of certain CMR decrees” dated by July 01, 2014;
Cabinet of Ministers Resolution No. 216 “On approval of medical devices, which operations for delivery in the customs territory of Ukraine and importation into the customs territory of Ukraine are to be taxable for VAT at the rate of 7 percents” dated by July 01, 2014;
Cabinet of Ministers Resolution No. 240 “On the amendments of certain CMR decrees” dated by March 23, 2016;
Cabinet of Ministers Resolution No. 501 “On Amendments to the CMR reglament (in respect of changes to item 2 of paragraph 40 for Chapter 3)” dated by Aug. 08, 2016;
Cabinet of Ministers Resolution No. 43 ‘On Amendments to the CMR order of Oct. 17, 2008, No. 955 and to the CMR order of Jul. 02, 2014, No. 240” dated by January 25, 2017 – regarding the cancellation of change declaring of the wholesale-sale price for medical devices;
MHU order No. 660 “On the recognition of the MHU order of Dec. 29, 2011, No. 1000, as invalid one” dated by Oct. 09, 2015;
MHU order No.361 “On amending the MHU order of July 16, 2012 No. 533” dated by April 13, 2016.
To find out more about speaking opportunities please contact:
Tel: +44 203 9504820